# EVI Industries, Inc.: financial statements, quarterly

EVI · NYSE · CIK 65312 · [Industrials](/sectors/industrials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/evi.md) · [Financials](/companies/evi/financials.md) · [Filings](/companies/evi/filings.md) · [Insiders](/companies/evi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/evi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [88.1](/filings/0001174947-24-001248.md) | [91.4](/filings/0001174947-25-000136.md) | [84.0](/filings/0001174947-25-000744.md) | [90.1 d](/filings/0002077096-25-000107.md) | [93.6](/filings/0001174947-25-001369.md) | [92.7](/filings/0001174947-25-000136.md) | [93.5](/filings/0001174947-25-000744.md) | [110 d](/filings/0002077096-25-000107.md) | [108](/filings/0001174947-25-001369.md) | [115](/filings/0001437749-26-003512.md) | [101](/filings/0001437749-26-016124.md) | [122 d](/filings/0001437749-26-029759.md) |
| Cost of revenue | $m | [62.4](/filings/0001174947-24-001248.md) | [65.0](/filings/0001174947-25-000136.md) | [58.2](/filings/0001174947-25-000744.md) | [62.8 d](/filings/0002077096-25-000107.md) | [64.8](/filings/0001174947-25-001369.md) | [65.2](/filings/0001437749-26-003512.md) | [65.5](/filings/0001437749-26-016124.md) | [76.0 d](/filings/0001437749-26-029759.md) | [74.4](/filings/0001174947-25-001369.md) | [79.8](/filings/0001437749-26-003512.md) | [68.3](/filings/0001437749-26-016124.md) | [83.4 d](/filings/0001437749-26-029759.md) |
| Gross profit | $m | [25.7](/filings/0001174947-24-001248.md) | [26.4](/filings/0001174947-25-000136.md) | [25.8](/filings/0001174947-25-000744.md) | [27.4 d](/filings/0002077096-25-000107.md) | [28.9](/filings/0001174947-25-001369.md) | [27.5](/filings/0001437749-26-003512.md) | [28.1](/filings/0001437749-26-016124.md) | [33.9 d](/filings/0001437749-26-029759.md) | [33.9](/filings/0001174947-25-001369.md) | [35.5](/filings/0001437749-26-003512.md) | [32.8](/filings/0001437749-26-016124.md) | [38.5 d](/filings/0001437749-26-029759.md) |
| Selling, general and administrative | $m | [23.1](/filings/0001174947-24-001248.md) | [23.5](/filings/0001174947-25-000136.md) | [23.4](/filings/0001174947-25-000744.md) | [23.7 d](/filings/0002077096-25-000107.md) | [23.9](/filings/0001174947-25-001369.md) | [25.1](/filings/0001437749-26-003512.md) | [25.8](/filings/0001437749-26-016124.md) | [29.8 d](/filings/0001437749-26-029759.md) | [30.3](/filings/0001174947-25-001369.md) | [31.3](/filings/0001437749-26-003512.md) | [30.6](/filings/0001437749-26-016124.md) | [32.8 d](/filings/0001437749-26-029759.md) |
| Operating income | $m | [2.6](/filings/0001174947-24-001248.md) | [3.0](/filings/0001174947-25-000136.md) | [2.4](/filings/0001174947-25-000744.md) | [3.7 d](/filings/0002077096-25-000107.md) | [5.0](/filings/0001174947-25-001369.md) | [2.4](/filings/0001437749-26-003512.md) | [2.3](/filings/0001437749-26-016124.md) | [4.1 d](/filings/0001437749-26-029759.md) | [3.6](/filings/0001174947-25-001369.md) | [4.2](/filings/0001437749-26-003512.md) | [2.3](/filings/0001437749-26-016124.md) | [5.6 d](/filings/0001437749-26-029759.md) |
| Interest expense | $m | [0.8](/filings/0001174947-24-001248.md) | [0.8](/filings/0001174947-25-000136.md) | [0.7](/filings/0001174947-25-000744.md) | [0.5 d](/filings/0002077096-25-000107.md) | [0.5](/filings/0001174947-25-001369.md) | [0.7](/filings/0001174947-25-000136.md) | [0.6](/filings/0001174947-25-000744.md) | [1.0 d](/filings/0002077096-25-000107.md) | [0.9](/filings/0001174947-25-001369.md) | [1.1](/filings/0001437749-26-003512.md) | [1.0](/filings/0001437749-26-016124.md) | [1.0 d](/filings/0001437749-26-029759.md) |
| Income tax | $m | [0.6](/filings/0001174947-24-001248.md) | [0.8](/filings/0001174947-25-000136.md) | [0.8](/filings/0001174947-25-000744.md) | [1.1 d](/filings/0002077096-25-000107.md) | [1.3](/filings/0001174947-25-001369.md) | [0.6](/filings/0001437749-26-003512.md) | [0.7](/filings/0001437749-26-016124.md) | [1.0 d](/filings/0001437749-26-029759.md) | [0.8](/filings/0001174947-25-001369.md) | [0.8](/filings/0001437749-26-003512.md) | [0.5](/filings/0001437749-26-016124.md) | [1.9 d](/filings/0001437749-26-029759.md) |
| Net income | $m | [1.3](/filings/0001174947-24-001248.md) | [1.3](/filings/0001174947-25-000136.md) | [1.0](/filings/0001174947-25-000744.md) | [2.1 d](/filings/0002077096-25-000107.md) | [3.2](/filings/0001174947-25-001369.md) | [1.1](/filings/0001437749-26-003512.md) | [1.0](/filings/0001437749-26-016124.md) | [2.1 d](/filings/0001437749-26-029759.md) | [1.8](/filings/0001174947-25-001369.md) | [2.4](/filings/0001437749-26-003512.md) | [0.8](/filings/0001437749-26-016124.md) | [2.7 d](/filings/0001437749-26-029759.md) |
| Diluted EPS | $ per share | [0.09](/filings/0001174947-24-001248.md) | [0.09](/filings/0001174947-25-000136.md) | [0.06](/filings/0001174947-25-000744.md) | not reported | [0.21](/filings/0001174947-25-001369.md) | [0.07](/filings/0001437749-26-003512.md) | [0.07](/filings/0001437749-26-016124.md) | not reported | [0.11](/filings/0001174947-25-001369.md) | [0.15](/filings/0001437749-26-003512.md) | [0.05](/filings/0001437749-26-016124.md) | not reported |
| Basic EPS | $ per share | [0.09](/filings/0001174947-24-001248.md) | [0.09](/filings/0001174947-25-000136.md) | [0.07](/filings/0001174947-25-000744.md) | not reported | [0.22](/filings/0001174947-25-001369.md) | [0.08](/filings/0001437749-26-003512.md) | [0.07](/filings/0001437749-26-016124.md) | not reported | [0.12](/filings/0001174947-25-001369.md) | [0.16](/filings/0001437749-26-003512.md) | [0.05](/filings/0001437749-26-016124.md) | not reported |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [4.2](/filings/0001174947-23-001380.md) | [4.3](/filings/0001174947-24-000199.md) | [3.3](/filings/0001174947-24-000726.md) | [4.6](/filings/0002077096-25-000107.md) | [4.4](/filings/0001174947-24-001248.md) | [3.9](/filings/0001174947-25-000136.md) | [5.9](/filings/0001174947-25-000744.md) | [8.9](/filings/0001174947-25-001369.md) | [4.7](/filings/0001174947-25-001369.md) | [4.3](/filings/0001437749-26-003512.md) | [4.3](/filings/0001437749-26-016124.md) | [6.8](/filings/0001437749-26-029759.md) |
| Current assets | $m | [122](/filings/0001174947-23-001380.md) | [117](/filings/0001174947-24-000199.md) | [110](/filings/0001174947-24-000726.md) | [102](/filings/0002077096-25-000107.md) | [112](/filings/0001174947-24-001248.md) | [113](/filings/0001174947-25-000136.md) | [115](/filings/0001174947-25-000744.md) | [145](/filings/0001437749-26-029759.md) | [158](/filings/0001174947-25-001369.md) | [153](/filings/0001437749-26-003512.md) | [153](/filings/0001437749-26-016124.md) | [141](/filings/0001437749-26-029759.md) |
| Total assets | $m | [249](/filings/0001174947-23-001380.md) | [247](/filings/0001174947-24-000199.md) | [239](/filings/0001174947-24-000726.md) | [231](/filings/0002077096-25-000107.md) | [246](/filings/0001174947-24-001248.md) | [249](/filings/0001174947-25-000136.md) | [252](/filings/0001174947-25-000744.md) | [307](/filings/0001437749-26-029759.md) | [322](/filings/0001174947-25-001369.md) | [316](/filings/0001437749-26-003512.md) | [318](/filings/0001437749-26-016124.md) | [304](/filings/0001437749-26-029759.md) |
| Current liabilities | $m | [70.7](/filings/0001174947-23-001380.md) | [72.2](/filings/0001174947-24-000199.md) | [72.3](/filings/0001174947-24-000726.md) | [69.8](/filings/0002077096-25-000107.md) | [77.8](/filings/0001174947-24-001248.md) | [71.7](/filings/0001174947-25-000136.md) | [76.2](/filings/0001174947-25-000744.md) | [94.9](/filings/0001437749-26-029759.md) | [112](/filings/0001174947-25-001369.md) | [96.8](/filings/0001437749-26-003512.md) | [95.5](/filings/0001437749-26-016124.md) | [86.1](/filings/0001437749-26-029759.md) |
| Total liabilities | $m | [115](/filings/0001174947-23-001380.md) | [115](/filings/0001174947-24-000199.md) | [106](/filings/0001174947-24-000726.md) | [94.1](/filings/0002077096-25-000107.md) | [109](/filings/0001174947-24-001248.md) | [111](/filings/0001174947-25-000136.md) | [112](/filings/0001174947-25-000744.md) | [164](/filings/0001437749-26-029759.md) | [181](/filings/0001174947-25-001369.md) | [172](/filings/0001437749-26-003512.md) | [172](/filings/0001437749-26-016124.md) | [154](/filings/0001437749-26-029759.md) |
| Long-term debt | $m | [33.9](/filings/0001174947-23-001380.md) | [30.9](/filings/0001174947-24-000199.md) | [21.9](/filings/0001174947-24-000726.md) | [12.9](/filings/0002077096-25-000107.md) | [19.9](/filings/0001174947-24-001248.md) | [27.9](/filings/0001174947-25-000136.md) | [24.0](/filings/0001174947-25-000744.md) | [53.0](/filings/0001437749-26-029759.md) | [51.0](/filings/0001174947-25-001369.md) | [58.0](/filings/0001437749-26-003512.md) | [60.0](/filings/0001437749-26-016124.md) | [51.0](/filings/0001437749-26-029759.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [134](/filings/0001174947-25-000136.md) | [132](/filings/0001174947-25-000744.md) | [133](/filings/0001174947-25-000744.md) | [137](/filings/0001437749-26-029759.md) | [136](/filings/0001437749-26-003512.md) | [138](/filings/0001437749-26-016124.md) | [140](/filings/0001437749-26-016124.md) | [143](/filings/0001437749-26-029759.md) | [141](/filings/0001437749-26-003512.md) | [144](/filings/0001437749-26-016124.md) | [146](/filings/0001437749-26-016124.md) | [150](/filings/0001437749-26-029759.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.5](/filings/0001174947-24-001248.md) | [9.3 d](/filings/0001174947-25-000136.md) | [9.4 d](/filings/0001174947-25-000744.md) | [12.4 d](/filings/0002077096-25-000107.md) | [0.2](/filings/0001174947-25-001369.md) | [2.0 d](/filings/0001437749-26-003512.md) | [9.1 d](/filings/0001437749-26-016124.md) | [9.9 d](/filings/0001437749-26-029759.md) | [1.0](/filings/0001174947-25-001369.md) | [4.0 d](/filings/0001437749-26-003512.md) | [2.2 d](/filings/0001437749-26-016124.md) | [13.4 d](/filings/0001437749-26-029759.md) |
| Capital expenditure | $m | [1.0](/filings/0001174947-23-001380.md) | not reported | not reported | not reported | not reported | not reported | [1.0 d](/filings/0001437749-26-016124.md) | [1.7 d](/filings/0001437749-26-029759.md) | not reported | not reported | [1.6 d](/filings/0001437749-26-016124.md) | [1.9 d](/filings/0001437749-26-029759.md) |
| Dividends paid | $m | not reported | not reported | [0.0 d](/filings/0001174947-25-000744.md) | [0.0 d](/filings/0002077096-25-000107.md) | not reported | not reported | [0.0 d](/filings/0001437749-26-016124.md) | [0.0 d](/filings/0001437749-26-029759.md) | not reported | not reported | [0.0 d](/filings/0001437749-26-016124.md) | [0.0 d](/filings/0001437749-26-029759.md) |
| Share repurchases | $m | [0.3](/filings/0001174947-24-001248.md) | [0.8 d](/filings/0001174947-25-000136.md) | [0.1 d](/filings/0001174947-25-000744.md) | [0.0 d](/filings/0002077096-25-000107.md) | [0.3](/filings/0001174947-25-001369.md) | [0.4 d](/filings/0001437749-26-003512.md) | [0.0 d](/filings/0001174947-25-000744.md) | [0.0 d](/filings/0002077096-25-000107.md) | [0.8](/filings/0001174947-25-001369.md) | [0.7 d](/filings/0001437749-26-003512.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.5](/filings/0001174947-23-001380.md) | [0.0](/filings/0001174947-24-000199.md) | [0.0](/filings/0001174947-24-000726.md) | [0.0](/filings/0001174947-24-001248.md) | [0.0](/filings/0001174947-25-000136.md) | [0.0](/filings/0001174947-25-000744.md) | [0.0](/filings/0001174947-25-001369.md) | [13.2](/filings/0001437749-26-003512.md) | [13.1](/filings/0001437749-26-016124.md) | [0.0](/filings/0001174947-25-001369.md) | [13.6](/filings/0001437749-26-003512.md) | [13.5](/filings/0001437749-26-016124.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,971,181 at 2026-10-16, from the cover of the [10-K/A filed 2026-10-22](/filings/0001437749-26-033252.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.